PictorLabs, a pioneering software company transforming histopathology with AI-powered virtual staining, announced the successful completion of its $30 million Series B funding round.

The round was led by global software investor Insight Partners, with continued participation from M Ventures, the venture capital arm of Merck KGaA, Darmstadt, Germany, which had previously led PictorLabs' Series A round. The infusion of capital will enable PictorLabs to further advance its technology, expand its market reach, and accelerate the adoption of AI-driven virtual staining in clinical and research settings.